Chase Investment Counsel Corp bought a new position in UnitedHealth Group Inc. (NYSE:UNH) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 28,705 shares of the healthcare conglomerate’s stock, valued at approximately $4,053,000. UnitedHealth Group makes up approximately 1.8% of Chase Investment Counsel Corp’s holdings, making the stock its 25th largest position.
Other large investors have also recently bought and sold shares of the company. Omega Advisors Inc. bought a new position in UnitedHealth Group during the first quarter worth approximately $64,386,000. Edgar Lomax Co. VA increased its position in UnitedHealth Group by 0.7% in the first quarter. Edgar Lomax Co. VA now owns 503,143 shares of the healthcare conglomerate’s stock worth $64,855,000 after buying an additional 3,438 shares during the period. Gateway Investment Advisers LLC increased its position in UnitedHealth Group by 8.8% in the second quarter. Gateway Investment Advisers LLC now owns 815,807 shares of the healthcare conglomerate’s stock worth $115,192,000 after buying an additional 66,274 shares during the period. Origin Asset Management LLP bought a new position in UnitedHealth Group during the first quarter worth approximately $34,616,000. Finally, Panagora Asset Management Inc. increased its position in UnitedHealth Group by 5.0% in the first quarter. Panagora Asset Management Inc. now owns 947,733 shares of the healthcare conglomerate’s stock worth $122,163,000 after buying an additional 44,707 shares during the period. 85.78% of the stock is owned by institutional investors.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded up 1.21% during trading on Friday, hitting $140.00. The stock had a trading volume of 4,164,080 shares. The firm has a 50 day moving average price of $138.43 and a 200-day moving average price of $135.92. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $144.48. The stock has a market capitalization of $133.33 billion, a price-to-earnings ratio of 21.91 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.89 by $0.07. The company had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. On average, equities research analysts forecast that UnitedHealth Group Inc. will post $7.90 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were given a dividend of $0.625 per share. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.79%. UnitedHealth Group’s payout ratio is 39.12%.
A number of research analysts recently commented on UNH shares. Mizuho boosted their price target on UnitedHealth Group from $156.00 to $160.00 and gave the company a “buy” rating in a research note on Tuesday, July 19th. Credit Suisse Group AG reaffirmed a “buy” rating and issued a $148.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Leerink Swann reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Citigroup Inc. boosted their price target on UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research note on Wednesday, July 20th. Finally, Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target for the company in a research note on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has assigned a strong buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $154.96.
In related news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.65% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.